Y. Armero

发表

Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis—The ESCAPE Study

C. Castillo, J. Gatell, Y. Yazdanpanah, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration

J. Gatell, A. Moreno, F. Marco, 2015, PloS one.

Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.

J. Gatell, A. Moreno, F. Marco, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis

J. Miro, C. Arias, A. Bayer, 2017, Antimicrobial Agents and Chemotherapy.

Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

J. Miro, J. Gatell, A. Moreno, 2009, Antimicrobial Agents and Chemotherapy.

High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis

J. Miro, A. Moreno, F. Marco, 2012, Antimicrobial Agents and Chemotherapy.

Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis

J. Gatell, A. Moreno, F. Marco, 2008, Antimicrobial Agents and Chemotherapy.

Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

J. Miro, J. Gatell, A. Moreno, 2008, Antimicrobial Agents and Chemotherapy.

Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis

D. Fuster, A. Moreno, G. Casals, 2017, The Journal of antimicrobial chemotherapy.

Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus

J. Miro, J. Gatell, A. Moreno, 2007, Antimicrobial Agents and Chemotherapy.

Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

J. Miro, J. Gatell, A. Moreno, 2015, Antimicrobial Agents and Chemotherapy.

Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity

J. Miro, J. Grau, A. Moreno, 2008, Scandinavian journal of infectious diseases.

Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis

K. Anstrom, C. Woods, M. Hannan, 2018 .

Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.

J. Gatell, A. Moreno, F. Marco, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early In Vitro and In Vivo Development of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to Daptomycin

J. Gatell, J. Vila, X. Vila-Farrés, 2013, Antimicrobial Agents and Chemotherapy.

AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis

D. Fuster, A. Moreno, F. Marco, 2017, Antimicrobial Agents and Chemotherapy.

Non-HACEK Gram-Negative Bacillus Endocarditis

Pierre Tattevin, Francisco Nacinovich, John Klein, 2007, Annals of Internal Medicine.

Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.

Suzanne R. Bradley, K. Anstrom, M. Hannan, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis

K. Anstrom, C. Woods, M. Hannan, 2016, Journal of the American Heart Association.

Left-sided infective endocarditis in patients with liver cirrhosis.

C. Castillo, J. Miro, H. Rodríguez-Abella, 2015, The Journal of infection.

Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

A. Moreno, F. Marco, C. Mestres, 2009, Antimicrobial Agents and Chemotherapy.